![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Shelton Richard C
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.4, Iss.7, 2003-07, pp. : 1175-1183
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Olanzapine/fluoxetine withdrawal: Mania: case report
Reactions Weekly, Vol. 1, Iss. 1093, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Olanzapine/fluoxetine promising in hard-to-treat depression
Inpharma, Vol. 1, Iss. 1352, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Spotlight on Olanzapine/Fluoxetine in Acute Bipolar Depression
By Deeks Emma D. Keating Gillian M.
CNS Drugs, Vol. 22, Iss. 9, 2008-01 ,pp. :